Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Thrombosis and Haemostasis|December 15, 1986
Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulfate in ratsV Diness, P B OstergaardCarbohydrate Research|January 3, 1995
Isolation and characterization of hexasaccharides derived from heparin. Analysis by HPLC and elucidation of structure by 1H NMRA Larnkjaer, S H Hansen, P B OstergaardThrombosis Research|July 15, 1994
Binding of low molecular weight heparin (Tinzaparin sodium) to bovine endothelial cells in vitroA Larnkjaer, P B Ostergaard, H J FlodgaardDiabetes Care|May 1, 1996
Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathyH Yokoyama, B Myrup, P Rossing, et al.Thrombosis Research|August 15, 1994
Pharmacokinetics of tinzaparin (Logiparin)--a low molecular weight heparin--after single and repeated intravenous administration in ratsP B Johansen, S N Rasmussen, P B OstergaardHaemostasis|January 1, 1996
Does glycosylation influence the experimental antithrombotic effect of a two-domain tissue factor pathway inhibitor?J Holst, B Lindblad, O Nordfang, et al.The Biochemical Journal|April 1, 1995
Structure of heparin fragments with high affinity for lipoprotein lipase and inhibition of lipoprotein lipase binding to alpha 2-macroglobulin-receptor/low-density-lipoprotein-receptor-related protein by heparin fragmentsA Larnkjaer, A Nykjaer, G Olivecrona, et al.Thrombosis Research|March 15, 1987
The effect of low molecular weight heparin on experimental thrombosis and haemostasis--the influence of production methodP B Ostergaard, B Nilsson, D Bergqvist, et al.Nephron|January 1, 1997
Proteoglycan expression in the normal rat kidneyC Pyke, P Kristensen, P B Ostergaard, et al.Thrombosis Research|June 15, 1985
The effect of heparin fragments of different molecular weights on experimental thrombosis and haemostasisD Bergqvist, B Nilsson, U Hedner, et al.Pageof 3